GoodRx Holdings
GDRX
192 hedge funds and large institutions have $5.14B invested in GoodRx Holdings in 2020 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 51 increasing their positions, 18 reducing their positions, and 64 closing their positions.
183% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 18
67% more first-time investments, than exits
New positions opened: 107 | Existing positions closed: 64
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
29% more funds holding
Funds holding: 149 → 192 (+43)
15.89% less ownership
Funds ownership: 305.43% → 289.54% (-16%)
24% less capital invested
Capital invested by funds: $6.73B → $5.14B (-$1.59B)
54% less call options, than puts
Call options by funds: $34.7M | Put options by funds: $76M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$104M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$54.5M |
| 3 |
ZCI
Zevenbergen Capital Investments
Edmonds,
Washington
|
+$54.5M |
| 4 |
Morgan Stanley
New York
|
+$48.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$125M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$72.3M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$41.2M |
| 4 |
JP Morgan Chase
New York
|
-$40.6M |
| 5 |
BAMCO Inc
New York
|
-$40.3M |
GDRX Hedge Fund Activity: Q4 2020 in Review
192 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q4 2020, worth a combined $5.14B — down 24% from $6.73B a quarter earlier.
Buyers outnumbered sellers: 107 funds opened new GDRX positions and 64 closed out — a net gain of 43 holders — while 51 added to existing stakes and 18 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $104M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $125M sold.
- 192 institutional investors held GoodRx Holdings (GDRX) as of Q4 2020, up from 149 in Q3 2020.
- Funds reported $5.14B of GoodRx Holdings stock for Q4 2020, down 24% quarter-over-quarter.
- 107 funds opened new GoodRx Holdings positions in Q4 2020 and 64 closed out, a net change of +43 holders.
- The largest GoodRx Holdings buyer in Q4 2020 was Goldman Sachs, an estimated $104M added.
- The largest GoodRx Holdings seller in Q4 2020 was T. Rowe Price Associates, an estimated $125M sold.
Based on aggregated 13F filings for Q4 2020.